Related Experiment Video
Updated: Jan 18, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Clinical Investigation of Rods and Rings Pattern in Anti-Nuclear Antibody Test in Korean Patients
Rods and rings (RR) immunofluorescence patterns in antinuclear antibody (ANA) testing may indicate underlying inflammatory processes. This finding is based on associations with autoimmune diseases, infections, and inflammatory conditions observed in a retrospective analysis.
Area of Science:
- Immunology
- Clinical Chemistry
Background:
- Antinuclear antibody (ANA) testing is crucial for diagnosing autoimmune diseases.
- Rods and rings (RR) immunofluorescence patterns are observed in ANA testing.
- The clinical significance of RR patterns requires further investigation.
Purpose of the Study:
- To investigate the clinical significance of rods and rings (RR) immunofluorescence patterns in antinuclear antibody (ANA) testing.
- To analyze the clinical associations of RR patterns.
Main Methods:
- A single-center retrospective analysis was performed.
- Data from January 2022 to December 2023 were examined.
- Cases with RR patterns in ANA testing were analyzed for clinical associations.
Main Results:
- Out of 40 cases (0.5%) with RR patterns, associations were found with autoimmune diseases (35%), infections (25%), and other inflammatory conditions (22.5%).
- High-intensity RR fluorescence showed a higher association with infections (45%) and autoimmune diseases (18%).
- Elevated inflammatory markers were present in 54.5% of cases with inflammatory manifestations.
Conclusions:
- Rods and rings (RR) patterns in ANA testing may serve as potential indicators of underlying inflammatory processes.
- These patterns can be associated with various conditions, including infections and autoimmune diseases.
More Related Videos
10:05Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018